Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary pulmonary hypertension.

E Oliaro1, W Grosso Marra, F Orzan

  • 1Cattedra di Cardiologia, Università degli Studi, Torino.

Minerva Cardioangiologica
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program.

International journal of cardiology·2026
Same author

Ostial stenosis of the left main coronary artery in a young woman 10 years after radiation therapy.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Inhaled nitric oxide versus sodium nitroprusside for preoperative evaluation of pulmonary hypertension in heart transplant candidates.

Transplantation proceedings·2013
Same author

Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report.

Transplantation proceedings·2013
Same author

Oculo-auriculo-vertebral spectrum (OAVS) with large cerebral cyst: affinity to holoprosencephaly.

Minerva pediatrica·2012
Same author

Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.

Neuropathology and applied neurobiology·2010
Same journal

Mechanistic factors of cardiovascular diseases.

Minerva cardioangiologica·2020
Same journal

Robotic-assisted coronary artery bypass grafting: current knowledge and future perspectives.

Minerva cardioangiologica·2020
Same journal

Features of degenerative mitral valve prolapse in the North East of China: repair characteristics, and short-term follow-up results.

Minerva cardioangiologica·2020
Same journal

Myocardial revascularization in chronic coronary syndromes: does viability matter?

Minerva cardioangiologica·2020
Same journal

Extracorporeal membrane oxygenation for COVID-19: effective weapon or futile effort?

Minerva cardioangiologica·2020
Same journal

Heart and endurance sports: excesses are often unhealthy.

Minerva cardioangiologica·2020
See all related articles

Primary Pulmonary Hypertension (PPH) is a rare condition causing high blood pressure in lung arteries, leading to heart failure. Research identifies risk factors and the gene for familial PPH, with vasodilation therapy as a key treatment.

Area of Science:

  • Cardiology
  • Genetics
  • Pharmacology

Background:

  • Primary Pulmonary Hypertension (PPH) is a rare, progressive disease characterized by elevated pulmonary arterial pressure and vascular resistance.
  • PPH can lead to right heart failure in the absence of secondary causes.
  • Identified risk factors include appetite suppressants, oral contraceptives, and hyperuricemia.

Purpose of the Study:

  • To examine identified risk factors for Primary Pulmonary Hypertension.
  • To discuss the genetic basis of familial PPH.
  • To outline current therapeutic strategies for PPH.

Main Methods:

  • Review of identified risk factors for PPH.
  • Discussion of genetic research identifying familial PPH genes.

Related Experiment Videos

  • Analysis of therapeutic approaches targeting pulmonary vasodilation.

    • Main Results:

    • Specific risk factors like appetite depressants, oral contraceptives, and hyperuricemia are associated with PPH.
    • Familial PPH, accounting for 6% of cases, is linked to an autosomal dominant inheritance pattern with incomplete penetrance.
    • Genes responsible for familial PPH have been identified by recent research.

    Conclusions:

    • Pulmonary vasoconstriction is the primary cause of PPH.
    • Vasodilation of the pulmonary arterial circulation is the main treatment goal.
    • Prostacyclin analogues, such as epoprostenol and iloprost, are key therapeutic agents.